Abstract
IntroductionErythropoietin (EPO) is a commonly used option in the treatment of chemotherapy-induced anaemia (CIA). However, ∼30–50% of patients fail to achieve an adequate response after initial treatment. Prior studies have...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have